Additional file 1: of MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis

Uccelli, Antonio; Laroni, Alice; Brundin, Lou; Clanet, Michel; Fernandez, Oscar; Nabavi, Seyed; Muraro, Paolo; Oliveri, Roberto; Radue, Ernst; Sellner, Johann; Soelberg Sorensen, Per; Sormani, Maria; Wuerfel, Jens; Battaglia, Mario; Freedman, Mark

doi:10.6084/m9.figshare.8105831.v1

13063_2019_3346_MOESM1_ESM.doc (256.5 kB)

Additional file 1: of MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis

journal contribution

posted on 2019-05-09, 05:00 authored by Antonio Uccelli, Alice Laroni, Lou Brundin, Michel Clanet, Oscar Fernandez, Seyed Nabavi, Paolo Muraro, Roberto Oliveri, Ernst Radue, Johann Sellner, Per Soelberg Sorensen, Maria Sormani, Jens Wuerfel, Mario Battaglia, Mark Freedman

SPIRIT 2013 checklist: Recommended items to address in a clinical trial protocol and related documents. (DOC 256 kb)

Funding

Fondazione Italiana Sclerosi Multipla

History

Usage metrics

Keywords

Multiple sclerosis Mesenchymal stem cells Mesenchymal stromal cells Clinical trial

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 1: of MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis

Funding

Fondazione Italiana Sclerosi Multipla

History

Usage metrics

Categories

Keywords

Licence

Exports